多发性硬化症的活体角膜共聚焦显微镜检查:能否区分多发性硬化症的疾病复发
这项前瞻性横断面研究纳入58例多发性硬化症患者(复发组27例、缓解组31例)和30名年龄性别匹配的健康对照,用活体角膜共聚焦显微镜评估角膜神经参数和树突状细胞密度。结果显示多发性硬化症患者较健康对照所有基底神经参数显著降低、树突状细胞密度显著升高,但复发组与缓解组间各参数无显著差异;复发组中16例复查显示角膜神经纤维密度和分支密度显著增加。结论认为单时间点活体角膜共聚焦显微镜检查似乎不足以确认复发,但有望显示早期神经再生。
要点
- 多发性硬化症患者较健康对照角膜神经纤维密度、长度、分支密度均显著降低,树突状细胞密度显著升高。
- 复发组与缓解组间角膜神经参数及树突状细胞密度均无显著差异。
- 复发组16例复查显示角膜神经纤维密度和分支密度显著增加,长度和树突状细胞密度无变化。
核心结论
- 多发性硬化症患者较健康对照可显示炎症增加和神经变性,但单时间点活体角膜共聚焦显微镜检查似乎不足以确认多发性硬化症患者复发。
- 活体角膜共聚焦显微镜检查有望显示多发性硬化症患者的早期神经再生。
研究设计与样本
- 前瞻性横断面研究,含亚组随访。
- 单中心研究纳入58例多发性硬化症患者(复发组27例、缓解组31例)和30名年龄性别匹配的健康对照。
- 排除有视神经炎或三叉神经症状病史的患者。
- 复发组中病情缓解≥6个月者复查活体角膜共聚焦显微镜。
主要发现
- 复发组与缓解组在年龄、性别、多发性硬化症病程和复发次数方面无统计学差异(P > .05)。
- 与健康对照相比,多发性硬化症患者所有基底神经参数显著降低(角膜神经纤维密度P < .001、角膜神经纤维长度P < .001、角膜神经分支密度P < .001),树突状细胞密度显著升高(P = .023)。
- 复发组与缓解组间角膜神经纤维密度平均(标准误)差-2.05(1.69)纤维/mm2(95%CI -1.32至5.43;P < .227)、角膜神经纤维长度平均(标准误)差-1.10(0.83)mm/mm2(95%CI -0.56至2.75;P < .190)、角膜神经分支密度平均(标准误)差-3.91(2.48)分支/mm2(95%CI -1.05至8.87;P < .120)、树突状细胞密度中位数(四分位距)59.38(43.75-85.0)vs 75.0(31.25-128.75)(P = .596)均无显著差异。
- 复发组复查(n = 16[59.3%])显示角膜神经纤维密度显著增加(P = .036)、角膜神经分支密度显著增加(P = .018),角膜神经纤维长度(P = .075)和树突状细胞密度(P = .469)无变化。
临床怎么用
- 原文结论认为单时间点活体角膜共聚焦显微镜检查似乎不足以确认多发性硬化症患者复发。
- 原文结论认为活体角膜共聚焦显微镜检查有望显示多发性硬化症患者的早期神经再生。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aims to investigate the role of in vivo corneal confocal microscopy (IVCCM) in the detection of corneal inflammatory activity and subbasal nerve alterations in patients with multiple sclerosis (MS) and to further determine whether IVCCM can be used to detect (acute) disease relapse. DESIGN: Prospective cross-sectional study, with a subgroup follow-up. METHODS: This single-center study included 58 patients with MS (MS-Relapse group [n = 27] and MS-Remission group [n = 31]), and 30 age- and sex-matched healthy control subjects. Patients with a history of optic neuritis or trigeminal symptoms were excluded. Corneal nerve fiber density (CNFD), corneal nerve branch density (CNBD), corneal nerve fiber length (CNFL), and dendritic cell (DC) density were evaluated in all patients with MS and control subjects by IVCCM. Patients in the MS-Relapse group who were in remission for ≥6 months after the MS incident underwent a repeat IVCCM. RESULTS: No statistical difference was observed between the MS-Relapse and MS-Remission groups regarding age, sex, MS duration, and the number of relapses (P > .05). Compared with healthy control subjects, all subbasal nerve parameters were significantly lower (CNFD: P < .001, CNFL: P < .001, CNBD: P < .001), and the DC density was significantly higher (P = .023) in patients with MS. However, no significant difference was observed between MS-Relapse and MS-Remission groups in terms of CNFD (mean [SE] difference -2.05 [1.69] fibers/mm2 [95% confidence interval {CI} -1.32 to 5.43]; P < .227), CNFL (mean [SE] difference -1.10 [0.83] mm/mm2 [95% CI -0.56 to 2.75]; P < .190), CNBD (mean [SE] difference -3.91 [2.48] branches/mm2 [95% CI -1.05 to 8.87]; P < .120), and DC density (median [IQR], 59.38 [43.75-85.0] vs 75.0 [31.25-128.75]; P = .596). The repeat IVCCM in relapse patients (n = 16 [59.3%]) showed a significant increase in CNFD (P = .036) and CNBD (P = .018), but no change was observed in CNFL (P = .075) and DC density (P = .469). CONCLUSION: Although increased inflammation and neurodegeneration can be demonstrated in patients with MS compared with healthy control subjects, a single time point evaluation of IVCCM does not seem to be sufficient to confirm the occurrence of relapse in patients with MS. However, IVCCM holds promise for demonstrating early neuroregeneration in patients with MS.
引用
- Dericioğlu V, Akkaya Turhan S, Erdem HE, et al. In Vivo Corneal Confocal Microscopy in Multiple Sclerosis: Can it Differentiate Disease Relapse in Multiple Sclerosis? Am J Ophthalmol. 2023. PMID: 36669610. doi:10.1016/j.ajo.2023.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。